The dominance of China, with 85 publications, and Italy, with 25, reflects complementary strengths rather than simple redundancy. Chinese groups have historically driven much of the fundamental materials chemistry of layered hydroxides, including refinements in co-precipitation, hydrothermal, and reconstruction methods that control layer charge density, interlayer spacing, and particle size, all of which govern how much antibiotic can be hosted and how quickly it escapes. Italian contributions, by contrast, have been closely associated with the biomedical translation of anionic clays, particularly in antitumoral and anti-inflammatory delivery, and that translational orientation naturally extends to antimicrobial applications where controlled release can reduce dosing frequency and limit the emergence of resistance at infection sites. The concentration of output in journals such as Applied Clay Science, the International Journal of Nanomedicine, and the International Journal of Biological Macromolecules illustrates the interdisciplinary position of the field: it sits at the intersection of clay mineralogy, nanomedicine, and macromolecular therapeutics, and authors must choose venues according to whether the novelty lies in the material synthesis or in the biological outcome.

The keyword co-occurrence findings, in which LDH, sustained release, and drug delivery emerge as central nodes, confirm that the community defines itself around the release kinetics problem rather than around any single antibiotic class. This is consistent with the underlying chemistry. The general formula of these materials, in which divalent and trivalent metal cations form positively charged hydroxide sheets balanced by interlayer anions and water, allows antibiotics bearing carboxylate, phosphate, or other anionic groups to be intercalated electrostatically. Once intercalated, release is governed by a combination of anion exchange with physiological counter-ions, partial dissolution of the layers, and diffusion through the particle periphery. Because the layers dissolve more readily in acidic media, the resulting carriers exhibit pronounced pH sensitivity, a property that is valuable at infected sites and in intracellular compartments such as phagolysosomes, where pH falls below that of blood and can be used to trigger preferential drug liberation. This same alkaline degradation behavior in gastric media, noted in the source literature, is a double-edged characteristic: it complicates oral delivery of acid-labile payloads yet can be exploited for gastric-responsive formulations.

The comparative framing against other carrier families provides useful context for interpreting why LDHs attract sustained attention despite their younger bibliography. Polyvinyl alcohol hydrogels are appreciated for biocompatibility and water processing but suffer from mechanical weakness and excessive hydrophilicity that accelerate burst release. Metal-organic frameworks offer exceptional internal surface area and tunable pore chemistry, yet concerns over long-term structural stability in aqueous biological environments, biodegradation products, and scalable cost remain active research questions. Mesoporous silica materials are the most clinically mature of the three comparators, but their typical pore dimensions constrain the size of molecules that can be loaded efficiently, and pore architecture influences release in ways that are difficult to tune independently. LDHs occupy a distinctive niche among these alternatives because their loading capacity is not limited by rigid pore windows; instead, the interlayer gallery can expand to accommodate bulky anionic species, and the layer charge can be adjusted through the divalent to trivalent cation ratio, giving formulators a direct handle on loading density and exchange kinetics. Their documented high anion exchange capacity, colloidal stability, and low toxicity in the reviewed literature further support this positioning.

The bibliometric emphasis on citation trends and thematic evolution also illuminates how the field has responded to the clinical backdrop of antimicrobial resistance. The 2022 GLASS report cited in the source article documents high resistance rates among common bacterial pathogens, and the parallel slowdown in the discovery of genuinely new antibiotic scaffolds has shifted attention toward maximizing the performance of existing drugs. Sustained-release delivery is one of the few strategies that improves the pharmacodynamic profile of an established antibiotic without requiring new chemistry at the molecular level. By flattening the sharp plasma spikes and troughs characteristic of immediate-release formulations, steady delivery maintains concentrations within the therapeutic window for longer periods, reduces the frequency of subinhibitory exposure that selects for resistant subpopulations, and improves patient adherence through fewer doses. In this sense, the bibliometric growth of LDH antibiotic delivery research can be read as a materials-science response to a pharmacological and epidemiological problem.

The methodological apparatus of the review itself deserves comment, because bibliometric analysis is increasingly used to map emerging biomedical materials fields and its limitations should be understood when interpreting the results. Restricting the corpus to English-language publications indexed in SCI-Expanded and ESCI introduces a selection bias toward established journals and anglophone or internationally publishing groups, which may undercount contributions from regions with strong domestic journals. The exclusion terms applied to remove degradation and adsorption studies, while scientifically justified, may also have removed hybrid papers that examined both adsorption and release. Nevertheless, the use of two complementary tools, VOSviewer for network visualization and the Bibliometrix package in R for descriptive and thematic statistics, strengthens the reliability of the mapping, since agreement between independent platforms on core findings such as country productivity and keyword clusters reduces the likelihood of software-specific artifacts. The reporting of total link strength as a measure of interaction intensity between nodes follows standard practice in science-mapping studies and allows readers to gauge not just the presence of a collaboration or co-occurrence but its relative weight within the network.

The identification of prominent authors, highly cited works, and funding sources within the 217-document corpus serves a practical function for newcomers to the field. Highly cited papers typically cluster around foundational demonstrations of antibiotic intercalation and release profiling, and tracing the citation flow from these works toward more recent publications reveals a thematic migration: early studies emphasized proof of concept for loading and release, while later work increasingly incorporates biological evaluation, including minimum inhibitory concentration assays, biofilm models, and cytocompatibility testing. The three-field plot analysis, which links countries, institutions, and keywords, exposes where interdisciplinary gaps persist, and the review’s framing of these gaps as opportunities for collaboration is consistent with the observation that no single discipline currently owns the problem. Materials chemists can optimize synthesis and interlayer architecture, microbiologists can define clinically relevant resistance and biofilm challenges, pharmacologists can model release and dosing, and toxicologists can establish biocompatibility thresholds, yet the bibliometric evidence suggests these communities have not fully converged.

The connection drawn between LDH drug delivery research and the Sustainable Development Goals reflects a broader trend in which bibliometric studies situate technical fields within global health priorities. Antimicrobial resistance is explicitly recognized in international frameworks as a threat to sustainable development, and delivery technologies that extend the useful life of existing antibiotics contribute to that agenda without demanding new molecular discovery. The emphasis on relevance to Sustainable Development Goals in the keyword and funding analysis indicates that funding agencies and journals increasingly reward work framed in these terms, which may in turn shape the direction of future publications toward applications with clear health-system relevance, such as wound dressings, implant coatings, and oral formulations for persistent infections.

Looking forward, the bibliometric evidence points toward several strategic directions that follow logically from the identified themes. First, the prominence of sustained release as a keyword suggests that quantitative release modeling, rather than qualitative demonstration, will be the differentiating contribution in coming years, since regulatory translation requires reproducible kinetics under physiologically relevant conditions. Second, the presence of gene therapy, biosensing, and ocular applications in the broader LDH literature signals that antimicrobial researchers may borrow formulation strategies from these adjacent domains, for example exploiting the positive surface charge that prolongs corneal residence to design mucoadhesive antimicrobial films. Third, the geographic concentration of output in two countries implies substantial untapped collaborative capacity, particularly in regions with high antimicrobial resistance burden but lower publication visibility in the indexed corpus, and international partnerships could align material development with the clinical epidemiology of resistance. Finally, the absence of prior bibliometric treatment of this field, which the review establishes as its central novelty, means that the 2025 dataset will serve as a baseline against which future updates can measure whether the field grows in volume, diversifies in geography, or shifts thematically from synthesis-oriented to clinically validated studies, and such longitudinal comparison is precisely the kind of insight that systematic bibliometric monitoring is designed to provide.

Subject of Research: Layered double hydroxides in sustained antibiotic delivery: a bibliometric review

Article Title: Layered double hydroxides in sustained antibiotic delivery: a bibliometric review

Article References: Verma, S. S., Varadavenkatesan, T., Selvaraj, R., & Vinayagam, R. (2026). Layered double hydroxides in sustained antibiotic delivery: a bibliometric review. Journal of Saudi Chemical Society, 30(5), Article 65. https://doi.org/10.1007/s44442-026-00120-7

Image Credits: AI Generated

DOI: 10.1007/s44442-026-00120-7

Keywords: Layered, double, hydroxides, sustained, antibiotic, delivery, bibliometric, review, scientific research

E. coli normally lives harmlessly in the intestinal tract, yet it is also the leading cause of many urinary tract infections. When the bacterium enters the urinary system, it can multiply in the bladder and, in some cases, travel to the kidneys or enter the bloodstream. Treatment traditionally relies on antibiotics selected according to local resistance patterns. However, repeated exposure to antibiotics creates evolutionary pressure: susceptible bacteria are eliminated, while variants carrying resistance mechanisms survive and reproduce. The Chennai study provides a detailed snapshot of how far that process has progressed in a population of urinary E. coli isolates examined in a diagnostic laboratory setting.

The investigators used the VITEK2 automated identification and antimicrobial susceptibility testing system, a platform widely used in clinical microbiology laboratories. The system determines whether bacterial growth is inhibited by specific antimicrobial agents and helps classify an isolate as susceptible, intermediate, or resistant according to laboratory standards. In this study, the antibiotic susceptibility card used was the GN-specific AST N-235 panel. The researchers then examined the results statistically and applied computational methods to reveal patterns that may be difficult to see when antibiotics are considered one at a time. This combination of routine laboratory testing, statistical analysis, and network science allowed the team to map resistance as an interconnected biological phenomenon.

The central result was striking: 70.5 percent of the isolates met the study’s definition of multidrug resistance. MDR generally refers to resistance to multiple antimicrobial categories, meaning that the bacterium is no longer vulnerable to several standard treatment options. The most prominent resistance was reported against nalidixic acid, ampicillin, and ticarcillin. Nalidixic acid is an older quinolone, while ampicillin and ticarcillin belong to the β-lactam family, a broad group that includes many drugs used against urinary and other bacterial infections. Resistance to these agents can reflect both long-standing antibiotic selection and the spread of bacterial lineages carrying multiple resistance genes.

The study also detected extended-spectrum β-lactamase production in 35.3 percent of the isolates. ESBLs are enzymes that break down a wide range of β-lactam antibiotics, including many penicillin and cephalosporin drugs. Their presence is clinically important because ESBL-producing bacteria can remain resistant even when a physician selects an antibiotic that would ordinarily be effective against E. coli. The genes encoding these enzymes are often carried on plasmids, small DNA molecules that can move between bacteria. This mobility enables resistance traits to spread not only through bacterial reproduction but also through horizontal gene transfer, allowing unrelated organisms to acquire similar defences.

To explore these relationships, the researchers constructed a co-resistance network. In this model, each node represented an antibiotic, while the connections between nodes reflected the number of isolates simultaneously resistant to both drugs. A stronger connection indicated that resistance to two antibiotics frequently appeared in the same bacterial isolates. The resulting network was concentrated around nalidixic acid, ampicillin, and ticarcillin, suggesting that resistance to these drugs was not occurring independently. Instead, it may have been linked by shared genetic elements, common exposure to antibiotic classes, or the expansion of bacterial clones carrying several resistance determinants.

Network analysis offers a different perspective from a conventional resistance table. A table can show that a bacterium is resistant to one drug at a particular frequency, but it does not necessarily reveal which resistances travel together. When several antibiotic resistances are tightly connected, prescribing one drug may indirectly select for bacteria resistant to others if the same genetic package or bacterial lineage carries multiple traits. These patterns can help microbiologists and public-health teams identify priority combinations for surveillance. They may also support antibiotic stewardship by showing where unnecessary or poorly targeted prescribing could reinforce a broader resistance network.

The researchers further investigated whether age was associated with antimicrobial resistance using logistic regression, a statistical method that estimates how a potential factor changes the odds of an outcome. Their analysis indicated a positive relationship between patient age and resistance to fluoroquinolone antibiotics. Older patients may have greater cumulative exposure to antibiotics, more frequent healthcare contact, recurrent urinary infections, or medical conditions that increase the likelihood of colonisation by resistant organisms. The study also reported that females accounted for a higher proportion of cases, with 75.5 percent reported in the analysis. This is consistent with the well-established observation that women experience UTIs more often, partly because of anatomical factors that facilitate the movement of intestinal bacteria into the urinary tract.

The findings carry implications beyond a single laboratory or city. They reinforce the need for urine cultures and susceptibility testing when infections are recurrent, severe, or unlikely to respond to first-line treatment. They also underline the importance of antimicrobial stewardship programmes, which aim to ensure that antibiotics are prescribed only when necessary, at the correct dose, for the appropriate duration, and with the narrowest effective spectrum. Surveillance systems can track changing resistance patterns, while infection-control measures can reduce the spread of resistant strains in healthcare environments. The authors argue that addressing MDR urinary infections will require coordinated action involving clinicians, laboratories, public-health authorities, and international monitoring networks.

Because the investigation was conducted at one diagnostic laboratory and covered a six-month period, its results may not represent every patient or healthcare setting in India. Nevertheless, the large number of isolates and the integration of laboratory data with co-resistance network analysis provide a valuable warning. E. coli is adapting to the antibiotic environment created by modern medicine, and the appearance of resistance to several drugs within the same isolates narrows the margin for safe and effective treatment. The study’s message is clear: urinary infections cannot be managed sustainably through prescribing habits alone. Continued resistance surveillance, better diagnostic testing, responsible antibiotic use, and collaboration across regions will be essential to prevent common bacterial infections from becoming increasingly difficult to control.

Subject of Research: Multidrug-resistant Escherichia coli isolates causing urinary tract infections, antimicrobial resistance patterns, ESBL production, co-resistance networks, and age-associated resistance.

Article Title: Prevalence and co-resistance network analysis of multidrug-resistant Escherichia coli isolates from urinary tract infections, a cross-sectional study

Article References: Srijith, L., Sivakumar, V., Parameswaran, R. et al. “Prevalence and co-resistance network analysis of multidrug-resistant Escherichia coli isolates from urinary tract infections, a cross-sectional study.” BMC Infectious Diseases (2026).

Image Credits: AI Generated

DOI: 10.1186/s12879-026-14213-6

Keywords: Multidrug-resistant Escherichia coli, urinary tract infections, antimicrobial resistance, extended-spectrum β-lactamase, ESBL, co-resistance network, fluoroquinolone resistance, antibiotic stewardship, logistic regression.